2003
DOI: 10.1016/s1044-0305(03)00265-4
|View full text |Cite
|
Sign up to set email alerts
|

Use of ProteinChip™ array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin β-4, a differentially secreted protein from lymphoblastoid cell lines

Abstract: The identification of proteins differentially expressed between cancer and normal cells is vital for the development of cancer diagnostics, therapeutics and vaccines. Using a ProteinChip Biomarker System (Ciphergen Biosystems, Fremont, CA) which combines ProteinChip™ technology with time-of-flight mass spectrometry, we have developed a simple method to screen and identify differentially secreted proteins from tumor cell lines. Mass spectra of the range of proteins secreted from normal B-cells were generated al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0

Year Published

2004
2004
2010
2010

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(18 citation statements)
references
References 15 publications
1
17
0
Order By: Relevance
“…Increased levels of human thymosin beta4 were found in melanoma-derived metastases (Clark 2000, Ridley 2000 and in a malignant mouse fibrosarcoma cell line (Kobayashi 2002). Thymosin beta4 was also detected in Epstein-Barr virus transformed B-cells in a differential screening experiment carried out by Diamond et al (2003). Wang et al (2003) could demonstrate changes in cultivated colon cancer cells towards malignant progression after overexpressing thymosin beta4.…”
Section: Introductionmentioning
confidence: 94%
“…Increased levels of human thymosin beta4 were found in melanoma-derived metastases (Clark 2000, Ridley 2000 and in a malignant mouse fibrosarcoma cell line (Kobayashi 2002). Thymosin beta4 was also detected in Epstein-Barr virus transformed B-cells in a differential screening experiment carried out by Diamond et al (2003). Wang et al (2003) could demonstrate changes in cultivated colon cancer cells towards malignant progression after overexpressing thymosin beta4.…”
Section: Introductionmentioning
confidence: 94%
“…Since the first report of Tb10 upregulation in renal cell carcinomas in 1991 [24], DNA array methodology has revealed a frequent correlation between dysregulated b-thymosin expression and tumour progression [9,29,[43][44][45][46][47][48][49][50][51][52]. In particular, increased b-thymosin levels were associated with augmented metastatic potential, presumably reflecting the need of these cell types both to migrate [43,44,47] and induce vascularisation.…”
Section: Tb4 and Tumour Progressionmentioning
confidence: 99%
“…However, YB-1, several isoforms of thymosin ␤, and also 14-3-3 have been demonstrated to be upregulated in several kinds of human cancers (17,24,49,51), suggesting that these genes are involved in the progression rather than the induction of tumors.…”
Section: Discussionmentioning
confidence: 99%